Home » AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal

AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal

August 2, 2026August 2, 2026

This post was originally published on this site.

Tie-up would create one of the world’s biggest drugmakers